Haolang Ming

483 total citations
18 papers, 321 citations indexed

About

Haolang Ming is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Haolang Ming has authored 18 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Haolang Ming's work include Glioma Diagnosis and Treatment (9 papers), MicroRNA in disease regulation (5 papers) and Cancer Cells and Metastasis (5 papers). Haolang Ming is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), MicroRNA in disease regulation (5 papers) and Cancer Cells and Metastasis (5 papers). Haolang Ming collaborates with scholars based in China, United States and Germany. Haolang Ming's co-authors include Shengping Yu, Xuejun Yang, Bingcheng Ren, Hai Long, Yi Li, Luqing Tong, Peidong Liu, Haiwen Ma, Feng Yuan and Yihan Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular Physiology and Cell Death and Disease.

In The Last Decade

Haolang Ming

18 papers receiving 317 citations

Peers

Haolang Ming

GENET

ONCOL

IMMUN

Fangling Cheng China

Zhennan Tao China

Lorenza Pasqualini Italy

Luyan Mu China

Gyöngyi Kudlik Hungary

Vasiliki Pantazopoulou Sweden

Zanina Grieg Norway

Yukihiro Shiraki Japan

Yu‐Wei Leu Taiwan

Raffaella Spina United States

Fangling Cheng China

Haolang Ming

153 ×0.9

96 ×0.9

87 ×1.2

GENET

68 ×1.0

ONCOL

63 ×1.1

IMMUN

Citations per year, relative to Haolang Ming Haolang Ming (= 1×) peers Fangling Cheng

Countries citing papers authored by Haolang Ming

Since Specialization

Citations

This map shows the geographic impact of Haolang Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolang Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolang Ming more than expected).

Fields of papers citing papers by Haolang Ming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haolang Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolang Ming. The network helps show where Haolang Ming may publish in the future.

Co-authorship network of co-authors of Haolang Ming

This figure shows the co-authorship network connecting the top 25 collaborators of Haolang Ming. A scholar is included among the top collaborators of Haolang Ming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolang Ming. Haolang Ming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wang, Sihan, Haolang Ming, Zhen Wang, et al.. (2025). NONHSAT141192.2 Facilitates the Stemness and Radioresistance of Glioma Stem Cells via the Regulation of PIK3R3 and SOX2. CNS Neuroscience & Therapeutics. 31(2). e70279–e70279. 1 indexed citations

Li, Yiming, Haolang Ming, Yu Lin, et al.. (2023). Ultra high b-value diffusion weighted imaging enables better molecular grading stratification over histological grading in adult-type diffuse glioma. European Journal of Radiology. 168. 111140–111140. 1 indexed citations

Yuan, Xi, Xiangdong Sun, Bin Zhou, et al.. (2023). HSPA4 regulated glioma progression via activation of AKT signaling pathway. Biochemistry and Cell Biology. 102(2). 159–168. 4 indexed citations

Li, Yiming, et al.. (2022). Advanced modalities and surgical theories in glioma resection. SHILAP Revista de lepidopterología. 5(2). 62–68. 1 indexed citations

Xin, Wenqiang, et al.. (2019). Predictable Risk Factors of Spontaneous Venous Thromboembolism in Patients Undergoing Spine Surgery. World Neurosurgery. 127. 451–463. 14 indexed citations

Yuan, Feng, Yi Li, Hai Long, et al.. (2019). Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses. Disease Markers. 2019. 1–13. 13 indexed citations

Yuan, Feng, Haolang Ming, Yingshuai Wang, et al.. (2019). Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples. Journal of Cellular Physiology. 235(5). 4326–4334. 39 indexed citations

Long, Hai, Peidong Liu, Shengping Yu, et al.. (2018). Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling. Cellular Physiology and Biochemistry. 51(6). 2925–2937. 18 indexed citations

Long, Hai, Tao Li, Xingchen Zhou, et al.. (2018). Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway. Cell Death and Disease. 9(2). 158–158. 63 indexed citations

10.

Tao, Zhennan, Tao Li, Haiwen Ma, et al.. (2018). Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation. Cell Death and Disease. 9(11). 1063–1063. 49 indexed citations

11.

Yang, Xuejun, Yi Li, Haolang Ming, Shengping Yu, & Bingcheng Ren. (2018). Ongoing evolution of response assessment in glioma: Where do we stand?. SHILAP Revista de lepidopterología. 1(3). 97–97. 1 indexed citations

12.

Ma, Haiwen, Tao Li, Zhennan Tao, et al.. (2018). NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathways. Journal of Cellular Physiology. 234(2). 1630–1642. 35 indexed citations

13.

Liu, Zhifeng, Xuejun Yang, Cong Chen, et al.. (2013). Expression of the Arp2/3 complex in human gliomas and its role in the migration and invasion of glioma cells. Oncology Reports. 30(5). 2127–2136. 47 indexed citations

14.

Zhang, Bin, Xuejun Yang, Shengping Yu, et al.. (2012). [Role of Rac1 in the SDF-1-induced migration and invasion of human glioma cell line U251].. PubMed. 92(11). 727–30. 2 indexed citations

15.

Zhang, Bin, Jian Sun, Shengping Yu, et al.. (2012). Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.. PubMed. 125(24). 4344–8. 5 indexed citations

16.

Yang, Xuejun, Huamin Wang, Wei Wang, et al.. (2011). Expression and distribution characteristics of human ortholog of mammalian enabled (hMena) in glioma. Chinese Journal of Cancer Research. 23(4). 312–316. 5 indexed citations

17.

Wang, Huamin, Xuejun Yang, Li Yu, et al.. (2011). [Correlation between the distribution of CD133-positive cells and the proliferation of microvessels in glioblastoma multiforme].. PubMed. 91(11). 781–5. 3 indexed citations

18.

Yu, Shengping, Xuejun Yang, Bin Zhang, et al.. (2011). Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.. PubMed. 124(17). 2599–604. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact